Stock RCE RECCE PHARMACEUTICALS LTD
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Recce Pharmaceuticals Ltd

Equities

RCE

AU000000RCE5

Market Closed - Australian S.E.
Other stock markets
 01:57:06 2024-05-16 am EDT 		5-day change 1st Jan Change
0.61 AUD 0.00% Intraday chart for Recce Pharmaceuticals Ltd -4.62% +15.89%
May. 15 Recce Pharmaceuticals Doses First Patient in Urosepsis Rapid Infusion Clinical Trial MT
May. 10 Recce Pharmaceuticals Finds 'Promising' Results From Nebulized RECCE 327 Pilot Study MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Recce Pharmaceuticals Ltd Completes Dosing First Subjects at 15-Minute Infusion Rate in a Phase I/II Trial of RECCE® 327 for Urinary Tract Infections and Urosepsis
CI
Recce Pharmaceuticals Ltd Announces Safety Committee Approves Faster Infusion Rate in Phase I/Ii Trial of Recce® 327 for Urinary Tract Infections and Urosepsis
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RCE Stock
  4. News Recce Pharmaceuticals Ltd
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW